SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Paracelsian Inc (PRLN)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: richard davis who wrote (1743)2/15/1997 8:44:00 AM
From: Richard Mazzarella   of 4342
 
Richard, I agree with you about the value for prostate cancer. However, the drug cocktails are causing the HIV virus to become even more resistant to treatment. That could result in vary nasty species moving into society. The AndroVir add-on minimizes that effect and IMO when John gets his "cocktail" (phone conference) going, watch the stock! Also there was some conjecture that AndroX can move through the blood/brain barrier. I understand that is a problem for some cocktails because the HIV virus hides there. There is also no question in my mind that AndroX will be patentable.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News